Daly, Roger J.
Scott, Andrew M.
Klein, Oliver
Ernst, Matthias
Article History
Received: 30 May 2022
Accepted: 19 September 2022
First Online: 29 September 2022
Declarations
:
: Not applicable.
: Not applicable.
: A.M.S. receives research funding from EMD Serono, ITM, Merck, Medimmune, Astra Zeneca, Telix, Adalta, Curis; O.K. receives research funding from Bristol Myers Squibb; and M. E receives research funding from Lassen Therapeutics.